Hedexin

Dry extract of Hederae folium, the active ingredient in Hedexin, is an expectorant presented as an oral dry extract for oral use. It is employed to help relieve cough, bronchitis and other upper respiratory tract infections in adults and children when indicated by a healthcare professional.

GNH USA supplies Hedexin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hedexin is an expectorant that acts on the respiratory tract to facilitate mucus clearance.

- Cough: promotes productive cough and aids expectoration of bronchial secretions. - Bronchitis: helps reduce mucus viscosity and supports airway clearance. - Upper respiratory tract infections: assists in relieving congestion and facilitating expectoration during viral or bacterial infections.

Hedexin may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset reported in some users. - Dyspepsia: occasional indigestion or heartburn. - Skin rash: transient erythema or itching at the site of contact.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with difficulty breathing or swelling. - Bronchospasm: paradoxical tightening of airway muscles. - Hepatic dysfunction: rare reports of elevated liver enzymes.

Before using Hedexin, consider the following precautions.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: use with caution and under medical advice. - Children: administer only under pediatric supervision. - Known hypersensitivity: avoid if allergic to ivy or related plants. - Concomitant medications: review all current drugs with a clinician. - Store at room temperature: keep in the original container, protect from moisture and light.

Potential drug interactions should be evaluated prior to therapy.

Major Interactions (Avoid): - Co‑administration with other herbal expectorants may increase gastrointestinal irritation. - Use with potent bronchodilators in uncontrolled asthma may precipitate bronchospasm.

Moderate Interactions (Monitor Closely): - Antihistamines may diminish the expectorant effect. - Cough suppressants (e.g., dextromethorphan) can counteract the intended action. - Certain anticoagulants may require monitoring due to rare hepatic effects.